Senior Software QA Automation Engineer, Cleerly
$171-184k
OTE
AI-powered heart disease diagnostics
Be an early applicant
AI-powered heart disease diagnostics
201-500 employees
Be an early applicant
$171-184k
OTE
201-500 employees
Company mission
To eliminate heart attacks by creating a new standard of care for the diagnosis of heart disease.
Role
Who you are
- Bachelor's degree in Computer Science, Information Technology, or related field. Or equivalent work experience
- 5+ years of experience in software quality engineering and development, with a strong focus on test automation
- Proficiency in writing end-to-end automated tests using frameworks such as Cypress
- Hands-on experience utilizing AWS Cloud Services or an equivalent enterprise cloud service provider
- Familiarity with manual testing methodologies and test result tracking tools like TestRail
- Experience with Cypress and Typescript, especially with the React framework
- Expertise in issue tracking and project management tools like JIRA
- Strong understanding of the software development life cycle and testing life cycle
- Excellent problem-solving, analytical, and critical thinking skills
Desirable
- Experience working in healthcare or another heavily-regulated industry
- Experience working in a start-up environment
What the job involves
- We are seeking an experienced Senior Software QA Automation Engineer to join our dynamic engineering team
- In this role, you will be responsible for designing, developing, and maintaining robust automation frameworks to ensure the quality and reliability of our software products
- Design and implement end-to-end automation test suites using industry-leading tools and frameworks
- Automate manual testing processes across the software development lifecycle (SDLC)
- Collaborate with cross-functional teams to understand requirements and translate them into comprehensive test plans
- Leverage technologies such as Cypress, AWS, and TestRail to optimize the testing process
- Integrate automation with issue tracking tools like JIRA to streamline the defect management workflow
- Continuously enhance the automation infrastructure and recommend improvements to increase efficiency
- Stay up-to-date with the latest trends and advancements in QA automation and share knowledge with the team
Our take
Traditional heart disease evaluation methods, such as a coronary angiogram, can be invasive - a catheter is threaded through the arm or leg to reach the heart, where it injects dye into its arteries so X-ray images can capture how blood flows through the vessels.
Though serious complications from the procedure are rare, they potentially include injury to the artery, an allergic reaction or kidney damage from the dye, as well as heart attack or stroke. This is a problem that Cleerly is trying to solve by measuring this plaque through AI-powered imaging which analyzes non-invasive coronary CT scans.
The company's continued success and growth, marked by recent funding, reflect the immense potential of its AI-driven imaging technology. With strong financial backing, the company is well-positioned to revolutionize heart disease screening and expand its market reach. As Cleerly moves closer to gaining full regulatory approval and broader coverage, its innovative approach to early detection could be a transformative impact on healthcare, making it an exciting company to watch in coming years.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
102% employee growth in 12 months
Company
Funding (last 2 of 6 rounds)
Dec 2024
$106m
SERIES C
Jul 2022
$223m
SERIES C
Total funding: $417.8m
Company benefits
- Comprehensive benefits package to support your health, growth, and work-life balance
- Choose from a variety of medical, dental, and vision plans that suit your needs
- We also offer an Employee Assistance Program (EAP)
- Flexible self-managed PTO
- Company holidays, including the week between Christmas Eve & New Year's Day, so you can recharge
- 401K with company match
- Generous parental leave
- Monthly stipends for WiFi/Internet and wellness
- Support your professional growth with annual stipends for learning and development
- Home office support
Company HQ
Central Business District, Denver, CO
Leadership
Dr. James Min
(Founder & CEO)Former Professor of Radiology and Medicine in Cardiology at Weill Cornell Medical College and the New York-Presbyterian Hospital. Former Director of the Dalio Institute of Cardiovascular Imaging.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 12 more jobs at Cleerly